A Canadian study found that a single dose of zoledronic acid may be as effective as seven doses for post-menopausal women with early-stage breast cancer. Researchers reported similar outcomes after five years, with fewer side effects, clinic visits, and treatment burdens, supporting a growing movement toward less intensive cancer care.
We'll keep you updated on all new application updates and features!